{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:32:11Z","timestamp":1790728331889,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jchromb.2024.124343","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:37:10Z","timestamp":1729643830000},"page":"124343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Quantification of tricyclic glycopeptide in human plasma by UHPLC-MS3 coupled with counter-extraction follow by protein precipitation to enhance sensitivity"],"prefix":"10.1016","volume":"1247","author":[{"given":"Luyao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124343_b0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ja.2014.111","article-title":"Glycopeptide antibiotics: back to the future","volume":"67","author":"Butler","year":"2014","journal-title":"J. Antibiot."},{"key":"10.1016\/j.jchromb.2024.124343_b0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the american society of health-system pharmacists, the infectious diseases society of america, and the society of infectious diseases pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jchromb.2024.124343_b0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/rcm.2364","article-title":"Investigation of vancomycin and related substances by liquid chromatography\/ion trap mass spectrometry","volume":"20","author":"Diana","year":"2006","journal-title":"Rapid Commun. Mass Spectrom: RCM."},{"key":"10.1016\/j.jchromb.2024.124343_b0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2024.124343_b0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1592\/phco.26.4.539","article-title":"Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant staphylococcus aureus pneumonia","volume":"26","author":"Scheetz","year":"2006","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.jchromb.2024.124343_b0030","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2024.124343_b0035","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ekir.2021.04.035","article-title":"Vancomycin-associated tubular casts and vancomycin nephrotoxicity","volume":"6","author":"Tantranont","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.jchromb.2024.124343_b0040","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. a literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2024.124343_b0045","first-page":"1361","volume":"71","author":"Rybak","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jchromb.2024.124343_b0050","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s11096-021-01266-7","article-title":"Vancomycin dosing and therapeutic drug monitoring practices: guidelines versus real-life","volume":"43","author":"Van Der Heggen","year":"2021","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.jchromb.2024.124343_b0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijantimicag.2010.10.030","article-title":"Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?","volume":"37","author":"Gould","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jchromb.2024.124343_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113429","article-title":"A sensitive HPLC-UV method for quantifying vancomycin in biological matrices: application to pharmacokinetic and biodistribution studies in rat plasma, skin and lymph nodes","volume":"189","author":"Ramadon","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124343_b0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients","volume":"49","author":"Lodise","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2024.124343_b0070","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/AAC.41.9.1985","article-title":"Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits","volume":"41","author":"Toyoguchi","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2024.124343_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/AAC.19.1.139","article-title":"Sensitive radioimmunoassay for vancomycin","volume":"19","author":"Fong","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2024.124343_b0080","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.17.4.654","article-title":"Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations","volume":"17","author":"Crossley","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2024.124343_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00007691-198309000-00017","article-title":"Automated fluorescence polarization immunoassay for monitoring vancomycin","volume":"5","author":"Schwenzer","year":"1983","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2024.124343_b0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.chroma.2017.01.012","article-title":"Monitoring of vancomycin in human plasma via portable microchip electrophoresis with contactless conductivity detector and multi-stacking strategy","volume":"1485","author":"Chong","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2024.124343_b0095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00007691-199011000-00009","volume":"12","author":"Hu","year":"1990","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2024.124343_b0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/09540105.2017.1293014","article-title":"Development of ic-ELISA and lateral-flow immunochromatographic assay strip for the detection of vancomycin in raw milk and animal feed","volume":"28","author":"Kong","year":"2017","journal-title":"Food Agric. Immunol."},{"key":"10.1016\/j.jchromb.2024.124343_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122151","article-title":"Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples","volume":"1148","author":"Milla","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2024.124343_b0110","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.3390\/molecules27217319","article-title":"An overview of analytical methodologies for determination of vancomycin in human plasma","volume":"27","author":"Cheng","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2024.124343_b0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0731-7085(98)00095-8","article-title":"A modified HPLC method for the determination of vancomycin in plasma and tissues and comparison to FPIA (TDX)","volume":"18","author":"Farin","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124343_b0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2017.04.003","article-title":"New liquid chromatography-tandem mass spectrometry method for routine TDM of vancomycin in patients with both normal and impaired renal functions and comparison with results of polarization fluoroimmunoassay in light of varying creatinine concentrations","volume":"469","author":"Brozmanov\u00e1","year":"2017","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.jchromb.2024.124343_b0125","doi-asserted-by":"crossref","DOI":"10.1097\/00007691-199602000-00013","article-title":"Instability of standard calibrators may be involved in overestimating vancomycin concentrations determined by fluorescence polarization immunoassay","volume":"18","author":"Morishige","year":"1996","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.jchromb.2024.124343_b0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/chromsci\/bmx089","article-title":"A Rapid and Simple HPLC Method for Therapeutic Monitoring of Vancomycin","volume":"56","author":"Lima","year":"2017","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2024.124343_b0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1590\/S0100-40422007000200029","article-title":"Analytical methods for vancomycin determination in biological fluids and in pharmaceuticals","volume":"30","author":"Vila","year":"2007","journal-title":"Quimica Nova."},{"key":"10.1016\/j.jchromb.2024.124343_b0140","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/AAC.00164-12","article-title":"2nd, Quality assessment of U.S. marketplace vancomycin for injection products using high-resolution liquid chromatography-mass spectrometry and potency assays","volume":"56","author":"Hadwiger","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2024.124343_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062439","article-title":"A high-performance liquid chromatography-mass spectrometry method for simultaneous determination of vancomycin, meropenem, and valproate in patients with post-craniotomy infection","volume":"28","author":"Jin","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2024.124343_b0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1570-0232(03)00068-0","article-title":"Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailability in rats","volume":"789","author":"Shibata","year":"2003","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jchromb.2024.124343_b0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/chir.22432","article-title":"Determination of trantinterol enantiomers in human plasma by high-performance liquid chromatography - tandem mass spectrometry using vancomycin chiral stationary phase and solid phase extraction and stereoselective pharmacokinetic application","volume":"27","author":"Qin","year":"2015","journal-title":"Chirality"},{"key":"10.1016\/j.jchromb.2024.124343_b0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2014.12.012","article-title":"Novel LC\u2013MS\/MS method for plasma vancomycin: Comparison with immunoassays and clinical impact","volume":"441","author":"Oyaert","year":"2015","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.jchromb.2024.124343_b0165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jchromb.2007.07.041","article-title":"Determination of vancomycin in serum by liquid chromatography\u2013high resolution full scan mass spectrometry","volume":"857","author":"Zhang","year":"2007","journal-title":"J. Chromatogr. b."},{"key":"10.1016\/j.jchromb.2024.124343_b0170","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s44211-022-00143-1","article-title":"Surface molecularly imprinted solid-phase extraction for the determination of vancomycin in plasma samples using HPLC\u2013MS\/MS","volume":"38","author":"Zhou","year":"2022","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jchromb.2024.124343_b0175","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.talanta.2018.08.006","article-title":"A rapid and easy method based on hydrophilic interaction chromatography coupled with tandem mass spectrometry (HILIC-MS\/MS\/MS) to quantify iodinated X-ray contrast in wastewaters","volume":"190","author":"Sordet","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2024.124343_b0180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/pr900864s","article-title":"MS\/MS\/MS reveals false positive identification of histone serine methylation","volume":"9","author":"Zhang","year":"2010","journal-title":"J. Proteome. Res."},{"key":"10.1016\/j.jchromb.2024.124343_b0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224003520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224003520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T23:22:30Z","timestamp":1737328950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224003520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"alternative-id":["S1570023224003520"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124343","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of tricyclic glycopeptide in human plasma by UHPLC-MS3 coupled with counter-extraction follow by protein precipitation to enhance sensitivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124343"}}